Barbieri et al. [34] showed that loss of TP63 in HNSCC cell lines led to the acquisition of a mesenchymal phenotype, which is compelling in light of the low expression levels of TP63 seen in MS. The gene discussed is TP63; the disease is myeloid sarcoma.